Clinical Trial Update: Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial evaluating pharmacokinetics, efficacy, and safety of perampanel oral suspension for reducing seizures in children on 1-3 stable antiepil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Fycompa (perampanel)

Snippet

Sponsor: Eisai Inc. | Conditions: Central Nervous System | Phase 2 | Status: COMPLETED | Results posted: 2015-08-28